Overcoming the diverse mechanisms of multidrug resistance in lung cancer cells by photodynamic therapy using pTHPP-loaded PLGA-lipid hybrid nanoparticles

Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment

Susan K. Hobbs, Wayne L. Monsky, Fan Yuan et al. · Proceedings of the National Academy of Sciences · 1998 · 2.4K citations

Medicine, Cancer Biology, Oncology +17

Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer

William K. Murphy, Frank V. Fossella, R Winn et al. · JNCI Journal of the National Cancer Institute · 1993 · 431 citations

Medicine, Oncology, Pharmacology +16

Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results

A. Y. Chang, K. Kim, John H. Glick et al. · JNCI Journal of the National Cancer Institute · 1993 · 339 citations

Medicine, Oncology, Pharmacology +12

A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells

Ho Lun Wong, Andrew M. Rauth, Reina Bendayan et al. · Pharmaceutical Research · 2006 · 299 citations

Pharmacy, Oncology, Pharmacology +10

Tumor heterogeneity and drug resistance.

Daniel L. Dexter, John T. Leith · Journal of Clinical Oncology · 1986 · 213 citations

Medicine, Cancer Biology, Oncology +15